NasdaqGS - Delayed Quote • USD
Praxis Precision Medicines, Inc. (PRAX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:16 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -2.07 | -2.19 | -8.78 | -9.54 |
| Low Estimate | -2.24 | -2.42 | -10.05 | -12.93 |
| High Estimate | -1.72 | -1.73 | -7.01 | -5.47 |
| Year Ago EPS | -10.65 | -7.35 | -18.69 | -8.78 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 1.83M | 170k | 2.3M | 1.47M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 5M | 800k | 5M | 5.83M |
| Year Ago Sales | -- | 781k | 2.45M | 2.3M |
| Sales Growth (year/est) | -- | -78.20% | -6.00% | -36.10% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -11.79 | -9.83 | -5.25 | -3.18 |
| EPS Actual | -10.65 | -7.35 | -2.7 | -2.97 |
| Difference | 1.14 | 2.48 | 2.55 | 0.21 |
| Surprise % | 9.70% | 25.20% | 48.60% | 6.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -2.07 | -2.19 | -8.78 | -9.54 |
| 7 Days Ago | -2.07 | -2.19 | -8.78 | -9.54 |
| 30 Days Ago | -2.07 | -2.26 | -8.98 | -9.66 |
| 60 Days Ago | -2.74 | -2.76 | -10.32 | -11.44 |
| 90 Days Ago | -2.93 | -2.91 | -11.74 | -26.43 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | PRAX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 80.60% | -- | -- | 6.50% |
| Next Qtr. | 70.20% | -- | -- | 12.00% |
| Current Year | 53.00% | -- | -- | 5.30% |
| Next Year | -8.70% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -14.60% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/26/2024 |
| Maintains | Jefferies: Buy to Buy | 3/26/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/26/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/6/2024 |
| Maintains | Wedbush: Neutral to Neutral | 1/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/5/2023 |
Related Tickers
PCVX Vaxcyte, Inc.
60.72
+1.10%
OLMA Olema Pharmaceuticals, Inc.
9.95
+1.22%
IMCR Immunocore Holdings plc
58.46
+0.79%
IMVT Immunovant, Inc.
27.17
-2.09%
CGEM Cullinan Therapeutics, Inc.
25.30
+31.43%
SWTX SpringWorks Therapeutics, Inc.
45.53
+3.01%
KALV KalVista Pharmaceuticals, Inc.
10.78
+2.76%
LXEO Lexeo Therapeutics, Inc.
12.50
+2.80%
ALXO ALX Oncology Holdings Inc.
16.86
-0.06%
INSM Insmed Incorporated
24.80
-0.48%